Utrecht, Netherlands

Pieter H Houba

This inventor holds 1 USPTO granted patent. Top assignee: Pharmachemie B.v.. Active years: 1998.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Pieter H Houba. Retrieved from https://idiyas.com/inventor/pieter-h-houba

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 29(Granted Patents)


Company Filing History:


Years Active: 1998

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Pieter H. Houba

Introduction

Pieter H. Houba is a notable inventor based in Utrecht, Netherlands. He has made significant contributions to the field of pharmaceuticals, particularly in the development of anthracycline derivatives. His work focuses on enhancing the efficacy of these compounds through innovative methods.

Latest Patents

One of Pieter H. Houba's key patents is related to anthracycline prodrugs. This patent details a method for the preparation of anthracycline derivatives that are coupled to an enzymatically cleavable N-phenyl-O-glycosyl carbamate spacer group. The derivatives are represented by a specific formula and include their acid addition salts. The patent also discusses the synthesis of these derivatives and their potential use, either alone or in combination with enzymes or antibody-enzyme conjugates.

Career Highlights

Pieter H. Houba is associated with Pharmachemie B.V., a company known for its focus on pharmaceutical innovations. His work at Pharmachemie has allowed him to explore and develop new therapeutic options that can significantly impact patient care.

Collaborations

Throughout his career, Pieter has collaborated with notable colleagues, including Ruben G. Leenders and Eric Wilhelmus Damen. These collaborations have contributed to the advancement of research and development in the pharmaceutical sector.

Conclusion

Pieter H. Houba's contributions to the field of pharmaceuticals, particularly through his innovative patent on anthracycline derivatives, highlight his role as a significant inventor. His work continues to influence the development of new therapeutic strategies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…